For immediate release: 16 December 2024
WIDEBLUE WARNS MED-TECH COMPANIES TO BEWARE OF DEVICE COSTS
Leading product development consultancy Wideblue has urged medical device innovators to consider health system economics when embarking on a project.
Dr Euan McBrearty, Head of Commercial and Innovation at Wideblue said: "Medical device inventors need firstly to ensure that their devices are safe and effective, however, increasing financial viability needs to be considered. Health services across the globe, and especially the NHS, are struggling financially and a device or treatment must meet strict fiscal criteria before it can be approved."
"Wideblue has worked on multiple medical device projects, many of which have revolutioned healthcare. As part of our due diligence, we always look at manufacturing and supply chain options and the impact this has on the cost of a potential medical device. This involves everything from choice of components to who will manufacture the end product whilst at the same time making sure that all the regulatory rules are met. For this reason, we recommend using an ISO-certified (ISO 13485) or FDA-registered manufacturer. Working with a specialist medical device manufacturer can reduce costs, speed up time to market and ensure high standards of quality and safety."
For more than 18 years, Wideblue has been at the forefront of medical device design using its skills in product design, mechanical, electronic and software design, physics, optics and photonics to help its clients turn their ideas into award-winning devices.
Clients include individuals, start-ups, technology research organisations, charities and social enterprises as well as global multinationals. Medical device projects have ranged from a personal capnometer and heated stretcher to a device for the early detection of sepsis and a low-cost ophthalmoscope.
For further information please visit www.wide-blue.com
-ends-
Media Contact:
Mike Reynolds
Integris Communications
T: 07748 635678
-//-